Health Law Daily Wrap Up, BLOG TRACKER—Noteworthy blog posts and other commentary, (May 7, 2026)
Law Firms Mentioned:Akerman LLP | Foley & Lardner LLP | Hyman, Phelps & McNamara, P.C. | Reed Smith LLP
Organizations Mentioned:Akerman, LLP | Foley & Lardner, LLP | Hyman Phelps & McNamara, PC | Reed Smith, LLP
By WK Editorial Staff
The week’s most insightful, intriguing, or entertaining blog posts from the health law community.
FDA Law Blog: “Sounds Great. Do You Want FDA Approval?” A Regulatory Analysis of Psychedelics, by Charles D. Snow & Kalie E. Richardson and Karla L. Palmer
STAT News: Top lawmaker takes aim at doctor lobby, linking AMA’s billing codes to fraud fight, by John Wilkerson
STAT News: Administration report on most favored nation drug pricing raises new details—and questions, by Daniel Payne
Health Industry Washington Watch Blog: DOJ Announces FCA Initiative for Data Miners, by Selina P. Coleman, Lesley C. Reynolds, Thomas H. Suddath, Jr., David A. Bender and Matthew K. Loughran
KFF Medicaid Blog: Status of State Medicaid Expansion Decisions
Health Law Rx: Fair Warning: HHS OIG’s New FAQs Caution that Fair Market Value and Stark-Compliant Arrangements Can Nonetheless Violate the Federal Anti-Kickback Statute, by John Hood
FDA Voices Blog: How FDA is Implementing Landmark Cosmetics Legislation to Positively Impact Public Health, by Steven Kozlowski
Drug & Device Law: The “Duty to Innovate” Arrives at the California Supreme Court: Oral Argument Set for May 6, 2026, by Steven Boranian
Health Care Law Today: FDA to Consider Lifting Restrictions on Numerous Compounded Peptides, by David L. Rosen, Nathan A. Beaver, William E. Holtz and Jessa Boubker
Health Care in Motion, Health Law & Policy, Commentary, Uncategorized: Tracking the Impact of HR 1 on State Budgets and Health Care Access
Have you seen (or written) a blog post that fits the bill? Send the HLD editors a note at HLD@wolterskluwer.com, with a link to the suggested post.
Attorneys: Charles D. Snow & Kalie E. Richardson and Karla L. Palmer (Hyman, Phelps & McNamara, P.C.). Selina P. Coleman, Lesley C. Reynolds, Thomas H. Suddath, Jr., David A. Bender, Matthew K. Loughran and Steven Boranian (Reed Smith LLP). John Hood (Akerman LLP). David L. Rosen, Nathan A. Beaver, William E. Holtz and Jessa Boubker (Foley & Lardner LLP).
IndustryNews: NewsStory CMSNews FDCActNews AntikickbackNews ConfidentialityNews CosmeticNews DrugBiologicNews FCANews FraudNews LabelingNews MedicaidNews EligibilityNews PrescriptionDrugNews PLDeviceNews PLDrugNews ProgramIntegrityNews StarkNews